{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:27:33Z","timestamp":1793935653132,"version":"4.8.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejpn.2026.09.001","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:28:26Z","timestamp":1788823706000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treatment responses to antiseizure medication in children with Angelman syndrome"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9602-4166","authenticated-orcid":false,"given":"Lena","family":"Manssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7741-8797","authenticated-orcid":false,"given":"Patrick","family":"Pfarrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1827-1434","authenticated-orcid":false,"given":"Janina","family":"Gburek-Augustat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9168-7615","authenticated-orcid":false,"given":"Ilona","family":"Krey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6277-3218","authenticated-orcid":false,"given":"Leonie","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7584-0811","authenticated-orcid":false,"given":"Malin","family":"Zaddach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4435-6610","authenticated-orcid":false,"given":"Johannes R.","family":"Lemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8484-5945","authenticated-orcid":false,"given":"Ingo","family":"Borggraefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4457-3794","authenticated-orcid":false,"given":"Christine","family":"Makowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejpn.2026.09.001_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ajmg.a.31074","article-title":"Angelman syndrome 2005: updated consensus for diagnostic criteria","volume":"140","author":"Williams","year":"2006","journal-title":"Am. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.ejpn.2026.09.001_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s13311-015-0361-y","article-title":"Angelman syndrome","volume":"12","author":"Margolis","year":"2015","journal-title":"Neurotherapeutics : JAme. Soc. Exper. NeuroTherapeutics"},{"key":"10.1016\/j.ejpn.2026.09.001_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2021.08.007","article-title":"Clinical characterization of epilepsy in children with angelman syndrome","volume":"124","author":"Cassater","year":"2021","journal-title":"Pediatr. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2026.09.001_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archneur.63.1.122","article-title":"Epilepsy in patients with angelman syndrome caused by deletion of the chromosome 15q11-13","volume":"63","author":"Valente","year":"2006","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2026.09.001_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1684\/j.1950-6945.2005.tb00095.x","article-title":"Analysis of the characteristics of epilepsy in 37 patients with the molecular diagnosis of angelman syndrome","volume":"7","author":"Galv\u00e1n-Manso","year":"2005","journal-title":"Epileptic Disord."},{"issue":"11","key":"10.1016\/j.ejpn.2026.09.001_bib6","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1111\/j.1528-1167.2009.02108.x","article-title":"Epilepsy in angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options","volume":"50","author":"Thibert","year":"2009","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ejpn.2026.09.001_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajmg.a.61382","article-title":"An overview of health issues and development in a large clinical cohort of children with angelman syndrome","volume":"182","author":"Bindels-de Heus","year":"2020","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejpn.2026.09.001_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yebeh.2016.04.030","article-title":"Seizure treatment in Angelman syndrome: a case series from the angelman syndrome clinic at Massachusetts general hospital","volume":"60","author":"Shaaya","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejpn.2026.09.001_bib9","article-title":"Antiseizure medications for lennox-gastaut syndrome: comprehensive review and proposed consensus treatment algorithm","volume":"164","author":"Samanta","year":"2025","journal-title":"Epilepsy Behav."},{"issue":"6","key":"10.1016\/j.ejpn.2026.09.001_bib10","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/epi.18338","article-title":"Updated classification of epileptic seizures: position paper of the international league against epilepsy","volume":"66","author":"Beniczky","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2026.09.001_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yebeh.2018.02.027","article-title":"Diazepam for outpatient treatment of nonconvulsive status epilepticus in pediatric patients with Angelman syndrome","volume":"82","author":"Worden","year":"2018","journal-title":"Epilepsy Behav."},{"issue":"3","key":"10.1016\/j.ejpn.2026.09.001_bib12","article-title":"A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome","volume":"10","author":"Duis","year":"2022","journal-title":"Mol. Genet. Genom. Med."},{"issue":"3","key":"10.1016\/j.ejpn.2026.09.001_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.seizure.2007.08.004","article-title":"Epilepsy in angelman syndrome","volume":"17","author":"Pelc","year":"2008","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.ejpn.2026.09.001_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.braindev.2020.08.014","article-title":"Epilepsy in Angelman syndrome: a scoping review","volume":"43","author":"Samanta","year":"2021","journal-title":"Brain Dev."},{"issue":"1","key":"10.1016\/j.ejpn.2026.09.001_bib15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ajmg.a.61940","article-title":"Clinical aspects of a large group of adults with Angelman syndrome","volume":"185","author":"den Besten","year":"2021","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.ejpn.2026.09.001_bib16","article-title":"Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents","volume":"1","author":"Brigo","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"20","key":"10.1016\/j.ejpn.2026.09.001_bib17","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1523\/JNEUROSCI.18-20-08505.1998","article-title":"Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome","volume":"18","author":"DeLorey","year":"1998","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.ejpn.2026.09.001_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.devbrainres.2005.03.014","article-title":"GABAA receptor beta3 subunit gene-deficient heterozygous mice show parent-of-origin and gender-related differences in beta3 subunit levels, EEG, and behavior","volume":"157","author":"Liljelund","year":"2005","journal-title":"Brain Res Dev Brain Res"},{"issue":"3","key":"10.1016\/j.ejpn.2026.09.001_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1528-1167.2006.00969.x","article-title":"Lamotrigine therapy of epilepsy with Angelman's syndrome","volume":"48","author":"Dion","year":"2007","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.ejpn.2026.09.001_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0893-133X(01)00385-2","article-title":"Lamotrigine increases gene expression of GABA-A receptor beta3 subunit in primary cultured rat hippocampus cells","volume":"26","author":"Wang","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.ejpn.2026.09.001_bib21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/epi4.12923","article-title":"Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first-line add-on therapies for seizures in Dravet syndrome: a network meta-analysis","volume":"9","author":"Guerrini","year":"2024","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.ejpn.2026.09.001_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/14656566.2025.2516630","article-title":"Current and emerging pharmacotherapies in lennox-Gastaut syndrome","author":"Samanta","year":"2025","journal-title":"Expert Opin. Pharmacother."},{"issue":"12","key":"10.1016\/j.ejpn.2026.09.001_bib23","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1172\/JCI130419","article-title":"Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice","volume":"129","author":"Gu","year":"2019","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.ejpn.2026.09.001_bib24","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/epi4.12948","article-title":"Successful use of cannabidiol in nonconvulsive status epilepticus in Angelman syndrome","volume":"9","author":"Pietrafusa","year":"2024","journal-title":"Epilepsia Open"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379826000978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379826000978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:05:23Z","timestamp":1793934323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379826000978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":24,"alternative-id":["S1090379826000978"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2026.09.001","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment responses to antiseizure medication in children with Angelman syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2026.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}